Pan Chen

1.2k total citations
38 papers, 857 citations indexed

About

Pan Chen is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Pan Chen has authored 38 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Cancer Research and 4 papers in Pharmacology. Recurrent topics in Pan Chen's work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (6 papers). Pan Chen is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (6 papers). Pan Chen collaborates with scholars based in China, United States and Hong Kong. Pan Chen's co-authors include Qianjin Liao, Zhaoyang Zeng, Bo Xiang, Xiayu Li, Zhaojian Gong, Wenling Zhang, Guiyuan Li, Ming Zhou, Lei Shi and Wei Xiong and has published in prestigious journals such as Nature Communications, Gut and Scientific Reports.

In The Last Decade

Pan Chen

37 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pan Chen China 15 593 475 175 101 88 38 857
Jing Zhu China 13 552 0.9× 334 0.7× 98 0.6× 127 1.3× 80 0.9× 45 818
Chao Shen China 14 779 1.3× 550 1.2× 89 0.5× 93 0.9× 134 1.5× 33 1.0k
Yaping Tian China 14 538 0.9× 486 1.0× 86 0.5× 76 0.8× 80 0.9× 27 805
Zhibin Liao China 21 794 1.3× 468 1.0× 181 1.0× 79 0.8× 85 1.0× 47 1.0k
Cui Li China 15 409 0.7× 311 0.7× 70 0.4× 31 0.3× 60 0.7× 47 657
Rufu Chen China 18 942 1.6× 947 2.0× 295 1.7× 90 0.9× 132 1.5× 28 1.3k
Fankai Meng China 19 612 1.0× 283 0.6× 327 1.9× 103 1.0× 112 1.3× 70 1.1k

Countries citing papers authored by Pan Chen

Since Specialization
Citations

This map shows the geographic impact of Pan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Chen more than expected).

Fields of papers citing papers by Pan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Chen. The network helps show where Pan Chen may publish in the future.

Co-authorship network of co-authors of Pan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Pan Chen. A scholar is included among the top collaborators of Pan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan Chen. Pan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Pan, Ying Lan, Ran Du, et al.. (2025). RNA interference‐based dsRNA application confers prolonged protection against rice blast and viral diseases, offering a scalable solution for enhanced crop disease management. Journal of Integrative Plant Biology. 67(6). 1633–1648. 2 indexed citations
2.
Song, Huiyi, Jianbin Zhang, Xinyue Jiang, et al.. (2024). Emodin nanocapsules inhibit acute pancreatitis by regulating lipid metabolic reprogramming in macrophage polarization. Phytomedicine. 130. 155763–155763. 10 indexed citations
3.
Guo, Jiayue, Pan Chen, Jie Wang, et al.. (2024). Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma. Nature Communications. 15(1). 8609–8609. 22 indexed citations
4.
Chen, Pan, et al.. (2024). Design, synthesis and bioactivity evaluation of cinnamic acid derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury. Bioorganic & Medicinal Chemistry Letters. 116. 130036–130036. 1 indexed citations
6.
Chen, Pan, Xiongzhi Quan, Xuejie Yang, et al.. (2024). Premature aging effects on COVID-19 pathogenesis: new insights from mouse models. Scientific Reports. 14(1). 19703–19703.
7.
Chen, Pan, Juyu Lian, Bin Wu, et al.. (2023). Draft genome of Castanopsis chinensis, a dominant species safeguarding biodiversity in subtropical broadleaved evergreen forests. BMC Genomic Data. 24(1). 78–78. 2 indexed citations
8.
Qiu, Chong, et al.. (2023). Enhanced tumor penetration across the blood-brain barrier: endoplasmic reticulum membrane hybrid siRNA nanoplexes. Materials Today Nano. 25. 100442–100442. 4 indexed citations
9.
Chen, Pan, Yong‐Liang Huang, Tao Huang, et al.. (2023). (Salen)osmium(VI) nitrides catalyzed glutathione depletion in chemotherapy. Chinese Chemical Letters. 34(10). 108153–108153. 4 indexed citations
10.
Chen, Pan, Ying Zhou, Xiaobo Li, et al.. (2023). Design, Synthesis, and Bioevaluation of Novel MyD88 Inhibitor c17 against Acute Lung Injury Derived from the Virtual Screen. Journal of Medicinal Chemistry. 66(10). 6938–6958. 13 indexed citations
11.
Wang, Anxin, Hongqiu Gu, Yijun Zhang, et al.. (2023). Urinary ketone bodies and stroke recurrence in patient with acute ischemic stroke or TIA. Journal of Clinical Neuroscience. 117. 79–83. 1 indexed citations
12.
13.
Yang, H. J., Bingyu Ding, Pan Chen, et al.. (2021). Design, synthesis and bioactivity evaluation of fisetin derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury. Bioorganic & Medicinal Chemistry. 49. 116456–116456. 7 indexed citations
14.
Wang, Yihong, et al.. (2021). Hsa_circ_0007637 Facilitates Nasopharyngeal Carcinoma Progression by Sponging miR-636/TPD52 Axis. Cancer Management and Research. Volume 13. 9439–9452. 7 indexed citations
15.
Liu, Tao, et al.. (2020). A cytotoxic nitrido-osmium(vi) complex induces caspase-mediated apoptosis in HepG2 cancer cells. Dalton Transactions. 49(47). 17173–17182. 8 indexed citations
16.
Chen, Pan, Qi Liu, & Xiaoling Wu. (2019). <p>HIF1α/miR-520a-3p/AKT1/mTOR Feedback Promotes The Proliferation And Glycolysis Of Gastric Cancer Cells</p>. Cancer Management and Research. Volume 11. 10145–10156. 25 indexed citations
17.
Shang, Chao, et al.. (2018). Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma. Cancer Chemotherapy and Pharmacology. 81(4). 671–678. 47 indexed citations
18.
Su, Min, Heran Wang, Wenxiang Wang, et al.. (2018). LncRNAs in DNA damage response and repair in cancer cells. Acta Biochimica et Biophysica Sinica. 50(5). 433–439. 50 indexed citations
19.
Ru, Yi, Xiaojie Chen, Wenzhi Guo, et al.. (2018). NEAT1_2&mdash;SFPQ axis mediates cisplatin resistance in liver cancer cells in vitro. OncoTargets and Therapy. Volume 11. 5695–5702. 26 indexed citations
20.
Luo, Jia, et al.. (2017). MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1. Oncology Reports. 38(2). 1067–1074. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026